Pricing Log in Create free account
Friday 6 November 2026 Export RDNT’s income statement to Excel — free account

RadNet, Inc.

RDNT Healthcare Diagnostics & Research

RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024.

Revenue
+25.0%
EPS
−47.4%
Free cash flow
−43.2%
Total debt
+21.2%

Quarter to June 2026, against a year earlier

77.28 0.73 −0.94%
Market cap
$6.1B
P/E
0.0×
Fwd P/E
1,050×
Dividend yield
—
F-score
3/9
Altman Z
2.04
Beneish M
−2.62
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

RadNet, Inc. (RDNT) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, RadNet, Inc. (RDNT) trades at a P/S ratio of 2.7×. Over the past ten years it has ranged from 0.3× (March 2016) to 3.6× (November 2024); the current reading is higher than 93% of that period. That is below the Diagnostics & Research industry median of 4.2× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 2.6× (5.68%)
FY2024 2.8× 105.11%
FY2023 1.4× 85.25%
FY2022 0.7× (38.96%)
FY2021 1.2× 29.36%
FY2020 0.9× 6.35%
FY2019 0.9× 74.11%
FY2018 0.5× (1.78%)
FY2017 0.5× 50.35%
FY2016 0.3× 1.61%

Quarterly newest first

Period P/S ratio Change
Jun 2026 2.1× 5.28%
Mar 2026 2.0× (23.62%)
Dec 2025 2.6× (10.52%)
Sep 2025 2.9× 32.51%
42 more quarters

Against its own ten years

Low 0.3× High 3.6×
Ten-year median 0.8×
Current reading's percentile 93

P/S ratio against peers

Company P/S ratio
ICLR ICON PLC compare 1.9×
RDNT RadNet, Inc. 2.7×
VCYT Veracyte, Inc. compare 3.3×
SHC Sotera Health Company compare 3.7×
QGEN QIAGEN N.V. compare 5.0×
CDNA CareDx, Inc. compare 8.1×
BLLN BillionToOne, Inc. compare 12.1×
ADPT Adaptive Biotechnologies Corporation compare 14.5×
GRAL GRAIL, Inc. compare 34.9×
Diagnostics & Research industry median 4.2×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on RDNT